Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases
Cardiovascular disease is the leading cause of death worldwide, and its prevalence is increasing due to the aging of societies. Atherosclerosis, a type of chronic inflammatory disease that occurs in arteries, is considered to be the main cause of cardiovascular diseases such as ischemic heart diseas...
Main Authors: | Eunhye Ji, Sahmin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/11/5770 |
Similar Items
-
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis
by: Núria Puig, et al.
Published: (2023-09-01) -
Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases
by: Barbara Kutryb-Zajac, et al.
Published: (2020-10-01) -
Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
by: Johan Frostegård
Published: (2023-06-01) -
The role of mitochondria in cardiovascular diseases related to atherosclerosis
by: Victor Yu Glanz, et al.
Published: (2020-01-01) -
Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors
by: Baltazar Hiram Leal, et al.
Published: (2022-01-01)